As per a recent report published by Fact.MR, the global minimally invasive surgery market is poised to grow at a CAGR of 5.2% from 2022 to 2032, reaching a valuation of US$ 10.5 Billion. This market growth is backed by the increased prevalence of chronic disorders and subsequent patients’ preference for minimal trauma-inducing surgeries.
As per a recent report published by Fact.MR, the global minimally invasive surgery market is poised to grow at a CAGR of 5.2% from 2022 to 2032, reaching a valuation of US$ 10.5 Billion. This market growth is backed by the increased prevalence of chronic disorders and subsequent patients’ preference for minimal trauma-inducing surgeries.
From 2015 to 2021, the market for Minimally Invasive Surgery grew at a CAGR of 4%, closing at a value of US$ 6 Billion. As of 2022, the industry is likely to reach US$ 6.3 Billion. Prospects heightened as healthcare practitioners advocated minimum reliance on open surgical procedures to offset the risk of contracting COVID via nosocomial routes.
Technological advancements in the healthcare industry and an upsurge in preference for hassle-free surgical procedures such as robotic surgery, laparoscopic surgery, and others are poised to fuel the sales of suppliers. Demand for bariatric minimally invasive surgery and cosmetic minimally invasive surgery is also seeing an incline.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5780
Key Takeaways from the Market Study:
Global market for minimally invasive surgery to expand 1.6x from 2022-2032
U.S to be an opportunistic market, expected to register a 4% value CAGR until 2032
China to open significant growth prospects for MIS, reaching a valuation of US$ 7.8 Billion
U.K, Japan and South Korea to register growth rates of 41.%, 4.6% and 4.5% respectively
By end users, hospitals and clinics to jointly account for half of all minimally invasive surgical procedures
Orthopedic minimally invasive surgeries to experience a CAGR of 4% from 2022-2032
“Medical practitioners are increasingly emphasizing on improving patient outcomes by incorporating numerous technological advancements, including robotic surgery and automation, generating new growth frontiers in the market,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Minimally Invasive Surgery Market
Aptar, Inc.; NingBo Seng Cze Macrospray Co. Ltd.; CLC Co. Ltd.; Yoshino Kogyosho Co. Ltd.; Knida Company Limited; Mitani Valve; Indian Harness; Silgan Dispensing; Dhiren PlastUniversity of Pittsburgh Medical Center; Rutland Medical Center; Huntington Hospital; Washington Hospital Healthcare System; The Ottawa Hospital; Michael’s Hospital; Ipswich Hospital; Apollo Hospitals Enterprise Limited; Healthcare Global Enterprises Ltd.ic Industry; Redcom Packaging Private Limited
Competitive Landscape
The global market for minimally invasive surgery is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.
In March 2019, the University of Pittsburgh Medical Centre firstly adopted RAMIE (Robot-Assisted Minimally Invasive Esophagectomy) Program and yielded excellent outcomes with increasing proficiency throughout the learning curve.
In Feb 2019, Huntington Hospital completed the acquisition of two da Vinci Xi Surgical Systems, the next generation in robotic surgical equipment. The da Vinci Xi System was designed to further advance the technology used in minimally invasive surgery, used across a spectrum of minimally invasive surgical procedures in gynecology, urology, thoracic, colorectal, and general surgery.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=5780
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global Minimally Invasive Surgery Market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights based on procedure (laparoscopic surgery, robotic surgery, endoscopic mucosal resection and endoscopic sub-mucosal dissection), end-user (hospitals, clinics, ambulatory surgical centres and other end users) and disorder type (orthopedic, cosmetic & bariatric, gynaecological, cardiothoracic, gastrointestinal, urological and other disorders)across five major regions (North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa).
Check out More Related Studies Published by Fact.MR:
Single Use Assemblies Market is projected to grow from USD 5,590 million in 2024 to USD 29,192 million by 2035, registering a CAGR of 15.6%.
Cutting Balloon Catheter Market was valued at US$ 180 million in 2020 and is expected to reach US$ 260 million by 2031 at a CAGR of 4%, with drug-delivery variants growing at 3% CAGR.
Surgical Medical Laser Systems Market is set to grow from US$ 3.18 billion in 2022 to US$ 7.68 billion by 2032, expanding at a CAGR of 9.2%.
Healthcare Contract Research Outsourcing Market is expected to rise from US$ 38.4 billion in 2020 to US$ 63.09 billion by 2028, growing at a CAGR of 6.6%.
Collagen and HA-Based Biomaterials Market is projected to increase from US$ 8 billion in 2022 to US$ 10.8 billion by 2027 at a CAGR of 6%, with facial aesthetics fillers growing at 6.5% CAGR to reach US$ 5.5 billion.
Wireless Health and Fitness Devices Market is forecast to grow from US$ 370 million to US$ 580 million between 2022 and 2026, at a CAGR of 12%.
Energy-Based Aesthetic Devices Market is valued at US$ 5.8 billion and expected to reach US$ 21.14 billion by 2032, growing at a CAGR of 13.8%.
Wound Care Biologics Market is projected to grow from US$ 2.09 billion to US$ 5.93 billion by 2032, registering a CAGR of 11%.
